Allen AM, Paxinos G., Song KF, Mendelsohn FAO . Localization of angiotensin receptor binding sites in the rat brain . In: Björklund A, Hökfelt T, Kuhar MJ (Eds.). Handbook of Chemical Neuroanatomy Vol. 11: Neuropeptide Receptors in the CNS .Amsterdam: Elsevier ; 1992;1-37.
2.
Saavedra JMBrain and pituitary angiotensin. Endocr Rev1992;13(2):329-80.
3.
Lenkei Z., Palkovits M., Corvol P., Llorens Cortes C.Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol1997;18:383-439.
4.
Phillips MI, Sumners C.Angiotensin II in central nervous system physiology. Regul Pept1998;78:1-11.
5.
Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KEIsolation of a cDNA encoding the vascular type-1 angiotensin II receptor . Nature1991;351:233-6.
6.
Kambayashi Y. , Bardhan S., Takahashi K. et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem1993;268:24543-6.
7.
Nakajima M., Mukoyama M., Pratt RE, Horiuchi M., Dzau VJCloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor . Biochem Biophys Res Commun1993;197:393-9.
8.
Phillips MIFunctions of angiotensin in the central nervous system. Annu Rev Physiol1987;49:413-35.
9.
Wright JW, Harding JWImportant role for angiotensin III and IV in the brain renin- angiotensin system. Brain Res Rev1997;25:96-124.
10.
Cote F., Laflamme L., Payet MD, Gallo-Payet N.Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr Res1998;24:403-7.
11.
Unger T.Inhibiting renin-angiotensin in the brain: the possible therapeutic implications . Blood Press2001;10(suppl 1):12-6.
12.
Reaux A., Fournie-Zaluski MC, Llorens-Cortes C.Angiotensin III: a central regulator of vasopressin release and blood pressure . Trends Endocrinol Metab2001;12:157-62.
13.
Malfroy B., Kado-Fong H., Gros C., Giros B., Schwartz JC, Hellmiss R.Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zincmetallohydrolases. Biochem Biophys Res Commun1989; 161:236-41.
14.
Wu Q., Lahti JM, Air GM, Burrows PD, Cooper MDMolecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc Natl Acad Sci USA1990;87:993-7.
Palmieri FE , Bausback HH,Ward PEMetabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. Biochem Pharmacol1989;38:173-80.
17.
Chauvel EN, Llorens-Cortes C., Coric P., Wilk S., Roques BP, Fournie-Zaluski MCDifferential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. J Med Chem1994;37:2950-7.
18.
Fournie-Zaluski MC, Coric P., Turcaud S. et al. Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation .JMed Chem1992;35:1259-66.
19.
Reaux A., de Mota N., Zini S. et al. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology1999;69:370-6.
20.
Cadel S., Pierotti AR, Foulon T. et al. Aminopeptidase-B in the rat testes: isolation, functional properties and cellular localization in the seminiferous tubules. Mol Cell Endocrinol1995;110:149-60.
21.
Zini S., Fournié-Zaluski MC, Chauvel E. et al. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA1996;93:11968-73.
22.
Lind RW, Swanson LW, Ganten D.Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus. Clin Exp Hypert1984;A6:1915-20.
23.
Lind RW, Swanson LW, Ganten D.Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system: An immunohistochemical study. Neuroendocrinology1985;40:2-24.
24.
Lind RW, Ganten D.Angiotensin. In: BjörklundA, HökfeltT, Kuhar MJ, (Eds). Handbook of Chemical Neuroanatomy. Amsterdam : Elsevier; 1990;165-286.
25.
Bumpus FM, Catt KJ, Chiu AT et al. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension1991;17:720-1.
26.
de Gasparo M., Catt KJ, Inagami T., Wright JW, Unger T.International union of pharmacology. XXIII. The angiotensin II receptorsPharmacol Rev2000;52:415-72.
27.
Sasaki K., Yamano Y., Bardhan S. et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature1991;351:230-3.
28.
Sandberg K. , Ji H., Clark AJ, Shapira H., Catt KJCloning and expression of a novel angiotensin II receptor subtype. J Biol Chem1992;267:9455-8.
29.
Sasamura H. , Hein L., Krieger JE et al. Cloning, characterization, and expression of two angiotensin receptor (AT-1) iso-forms from the mouse genome. Biochem Biophys Res Comm1992;185:253-9.
30.
Ohyama K., Yamano Y., Sano T. et al. Disulfide bridges in extracellular domains of angiotensin II receptor type IA. Regul Pept1995;57:141-7.
31.
Lenkei Z., Palkovits M., Corvol P., Llorens-Cortes C.Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol1997;18:383-439.
32.
Conchon S., Monnot C., Teutsch B., Corvol P., Clauser E.Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements. FEBS Lett1994 ;349:365-70.
33.
Martin MM, White CR, Li H., Miller PJ, Elton TSA functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR). Regul Pept1995;60:135-47.
34.
Hunyady L., Gaborik Z., Vauquelin G., Catt KJStructural requirements for signalling and regulation of AT(1)- receptors . JRAAS2001;2:16-23.
35.
Berry C., Touyz R., Dominiczak AF, Webb RC, Johns DGAngiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol2001;281:H2337-65.
36.
Gallinat S. , Busche S., Raizada MK, Sumners C.The angiotensin II type 2 receptor: an enigma with multiple variations . AmJPhysiolEndocrinolMetab2000;278:E357-74.
37.
Rowe BP, Grove KL, Saylor DL, Speth RCAngiotensin II receptor subtypes in the rat brain. Eur J Pharmacol1990; 186:339-42.
38.
Allen AM, Zhuo J., Mendelsohn FALocalization and function of angiotensin AT1 receptors. Am J Hypertens2000;13:31S-38S.
39.
Bunnemann B. , Iwai N., Metzger R. et al.The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain. Neurosci Lett1992;142:155-8.
40.
Lenkei Z., Corvol P., Llorens-Cortes C.The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control . Mol Brain Res1995;30:53-60.
41.
Lenkei Z., Palkovits M., Corvol P., Llorens-Cortes C.Distribution of angiotensin II type-2 receptor (AT2) mRNA expression in the adult rat brain. J Comp Neurol1996 ;373:322-39.
42.
Wright JW, Harding JWBrain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev1994;18:21-53.
43.
Lenkei Z., NuytAM, Grouselle D., Corvol P., Llorens-Cortes C.Identification of endocrine cell populations expressing the AT1B subtype of angiotensin II receptors in the anterior pituitary. Endocrinology1999;140:472-7.
44.
Johnson AK, Zardetto-Smith AM, Edwards GLIntegrative mechanisms and the maintenance of cardiovascular and body fluid homeostasis: the central processing of sensory input derived from the circumventricular organs of the lamina terminalis. Prog Brain Res1992;91:381-93.
45.
Johnson AK, Edwards GLThe neuroendocrinology of thirst:Afferent signaling and mechanisms of central integration. Current Topics in Neuroendocrinology1990;10:149-90.
46.
McKinley MJ , Bicknell RJ, Hards D. et al. Efferent neural pathways of the lamina terminalis subserving osmoregulation. Prog Brain Res1992;91:395-402.
47.
Simpson JBThe circumventricular organs and the central actions of angiotensin . Neuroendocrinology1981;32:248-56. 48. Miselis RR, Shapiro RE, Hand PJSubfornical organ efferents to neural systems for control of body water. Science1979;205:1022-5.
48.
Tanaka J., Saito H., Kaba H., Seto K.Subfornical organ neurons act to enhance the activity of paraventricular vasopressin neurons in response to intravenous angiotensin II. Neurosci Res1987;4:424-7.
49.
Ferguson AVNeurophysiological analysis of mechanisms for subfornical organ and area postrema involvement in autonomic control. Prog Brain Res1992;91:413-21.
50.
Johnson AK, Cunningham JT, Thunhorst RLIntegrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol1996;23:183-91.
51.
Epstein ANThe physiology of thirst. Can J Physiol Pharmacol1976;54:369.
52.
Nazarali AJ , Gutkind JS, Saavedra JMRegulation of angiotensin II binding sites in the subfornical organ and other rat brain nuclei after water deprivation . Cell Mol Neurobiol1987 ;7:447-55.
53.
Rowland NE, Rozelle A., Riley PJ, Fregly MJEffect of non-peptide angiotensin receptor antagonists on water intake and salt appetite in rats. Brain Res Bull1992 ;29:389-93.
54.
Hogarty DC, Speakman EA, Puig V., Phillips MIThe role of angiotensin,AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res1992;586:289-94.
55.
Ichiki T., Labosky PA, Shiota C. et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature1995;377:748-50.
56.
Hein L., Barsh G., Pratt RE, Dzau VJ, Koblika BKBehavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice.Nature1995 ;377:744-7.
57.
Gordon FJ, Johnson AKElectrical stimulation of the septal area in the rat: Prolonged suppression of water intake and correlation with self-stimulation. Brain Res1981;206:421-30.
58.
Bargmann W. , Scharrer E.The site of origin of the hormones of the posterior pituitary. Am Sci1951;39:255-9.
59.
Renaud LP, Bourque CWNeurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Prog Neurobiol1991;36:131-69.
60.
Veltmar A., Culman J., Qadri F., Rascher W., Unger T.Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther1992;263:1253-60.
61.
Hoffman LH, Phillips MI, Schmid PG, Falcon J., Weet JFAntidiuretic hormone release and the pressor response to central angiotensin II and cholinergic stimulation. Neuropharmacology1977;16:463-72.
62.
Tsushima H. , Mori M., Matsuda T.Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors . Jpn J Pharmacol1994;66:241-6.
63.
Ferguson AV , Wall KMCentral actions of angiotensin in cardiovascular control: multiple roles for a single peptide. Can J Physiol Pharmacol1992;70:779-85.
64.
Li Z., Ferguson AVSubfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am J Physiol1993;265:R302-9.
65.
Stadler T., Veltmar A., Qadri F., Unger T.Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats. Brain Res1992;569:117-22.
66.
Phillips MI , Shen L., Richards EM, Raizada MKImmunohistochemical mapping of angiotensin AT1 receptors in the brain. Regul Pept1993 ;44:95-107.
67.
Reagan LP, Flanagan-Cato LM, Yee DK et al. Immunohistochemical mapping of angiotensin type 2 (AT2) receptors in rat brain. Brain Res1994;662:45-59.
68.
Harding JW, Jensen LL, Hanesworth JM et al. Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. Am J Physiol1992;262:F17-23.
69.
Hall JEThe renin-angiotensin system: renal actions and blood pressure regulation . Compr Ther1991;17:8-17.
70.
Epstein ANNeurohormonal control of salt intake in the rat. Brain Res Bull1991;27:315-20.
71.
Gutkind JS, Kurihara M., Castren E., Saavedra JMIncreased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats. J Hypertens1988; 6:79-84.
72.
Fluharty SJ , Epstein ANSodium appetite elicited by intracerebroventricular infusion of angiotensin II in the rat. Synergistic interaction with systemic mineralocorticoids. Behav Neurosci1983;97:746-58.
73.
Yang ZF, Epstein ANBlood-borne and cerebral angiotensin and the genesis of salt intake . Horm Behav1991; 25:461-76.
74.
Fitts DA, Masson DBPreoptic angiotensin and salt appetite. Behav Neurosci1990;104:643-50.
75.
Stellar E., Epstein ANNeuroendocrine factors in salt appetite. J Physiol Pharmacol1991;42:345-55.
76.
Diz DI, Barnes KL, Ferrario CMContribution of the vagus nerve to angiotensin II binding sites in the canine medulla. Brain Res Bull1986;17:497-505.
77.
Allen AM, Sasaki S., Dampney RAL, Mendelsohn FAOActions of angiotensin II in the ventrolateral medulla oblongata. Central Neural Mech Cardiovasc Regul1991;1:95-103.
78.
Palkovits M. , Zaborszky L.Neuroanatomy of central cardiovascular control. Nucleus tractus solitari: afferent and efferent neuronal connections in relation to the baroreceptor reflex arc. Prog Brain Research1977;47:1-34.
79.
Launer LJ, Masaki K., Petrovitch H., Foley D., Havlik RJThe association between midlife blood pressure levels and late-life cognitive function.The Honolulu-Asia Aging Study. JAMA1995; 274:1846-51.
80.
Elias PK, D'Agostino RB, Elias MF, Wolf PABlood pressure, hypertension, and age as risk factors for poor cognitive performance . Exp Aging Res1995;21(4):393-417.
81.
RigaudAS,Hanon O. , Seux ML, Forette F.Hypertension and dementia . Curr Hypertens Res2001;3:454-7.
82.
Starr JM, Whalley LJ, Deary IJThe effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc1996 ;44:411-15.
83.
Cervilla JA , Prince M., Joels S., Lovestone S., Mann A.Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry2000;177:66-71.
84.
Mondadori C. , Etienne P.Nootropic effects of ACE inhibitors in mice . Psychopharmacology1990;100:301-07.
85.
Costall B., Coughlan J., Horovitz ZP et al.The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav1989;33:573-9.
86.
Barnes JM, Barnes NM, Costall B. et al. Angiotensin II inhibits cortical cholinergic function: implications for cognition. J Cardiovasc Pharmacol1990 ;16:234-8.
87.
Barnes JM, Barnes NM, Costall B., Horovitz ZP, Naylor RJAngiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro. Brain Res1989 ;491:136-43.
88.
Bartus RT, Dean RL, 3rd, Beer B., LippaASThe cholinergic hypothesis of geriatric memory dysfunction. Science1982; 217:408-14.
89.
Barnes NM, Champaneria S., Costall B. et al. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport1990;1:239-42.
90.
Barnes NM, Costall B., Kelly ME, Murphy DA, Naylor RJCognitive enhancing actions of PD123177 detected in a mouse habituation paradigm . Neuroreport1991;2:351-3.
91.
Jakab RL, Leranth C.Septum. In: Paxinos G, (Ed). The Rat Nervous System, Second Edition. London: Academic Press; 1994.
92.
Abhold RH, Sullivan MJ, Wright JW, Harding JWBinding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. J Pharmacol Exp Ther1987;242:957-62.
93.
Wright JW, Morseth SL, Abhold RH, Harding JWPressor action and dipsogenicity induced by angiotensin II and III in rats . Am J Physiol1985; 249: R514-R21.
94.
Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JWStructure-function analyses of brain angiotensin control of pressor action in rats. Am J Physiol1989;257:R1551-7.
95.
Felix D., Schlegel W.Angiotensin receptive neurones in the subfornical organ. Structure-activity relations. Brain Res1978; 49:107-16.
96.
Harding JW, Felix D.Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res1987;410:130-4.
97.
Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JWIntracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Brain Res1990;514:5-10.
98.
Batt CM, Klein EW, Harding JW,Wright JWPressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran . Brain Res Bull1988;21:731-5.
99.
Reaux A., Fournie-Zaluski MC, David C. et al. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA1999;96:13415-20.
100.
Wright JW, Mitzutani S., Murray CE, Amir HZ, Harding JWAminopeptidase-induced elevation and reduction in blood pressure in the spontaneously hypertensive rat. J Hypertension1990;8:969-74.
101.
Wright JW, Jensen LL, Cushing LL, Harding JWLeucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats. Hypertension1989;13:910-15.
102.
Song L., Wilk S., Healy DPAminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Res1997;744:1-6.
103.
Waksman G. , Bouboutou R., Devin J. et al. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur J Pharmacol1985;117:233-43.
104.
Llorens-Cortes C., Gros C., Schwartz JCSteady-state level and turnover rate of the tripeptide Tyr-Gly-Gly as indexes of striatal enkephalin release in vivo and their reduction during pentobarbital anesthesia. Proc Natl Acad Sci USA1986; 83:6226-30.
105.
Ferrario CM , Chappell MC,Tallant EA, Brosnihan KB, Diz DICounterregulatory actions of angiotensin-(1-7) . Hypertension1997;30:535-41.
106.
Chansel D. , Czekalski S.,Vandermeersch S., Ruffet E., Fournie-Zaluski MC, Ardaillou R.Characterization of angiotensin IVdegrading enzymes and receptors on rat mesangial cells. Am J Physiol1998 ;275:F535-42.
107.
Teruya H., Muratani H.,Takishita S. et al. Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats. J Hypertens1995;13:883-90.
